32K iOS Apps Tracked Updated 1 h ago Revenue Forecasts
Add an app Create Account Sign In
Home

PillEye – tablet, pill counter

41
Quality Score
Emerging

PillEye – tablet, pill counter

by Medility Inc.
Medium confidence
2.9 App Store rating
✍️ Bumetric analysis

PillEye – tablet, pill counter is an iOS app from Medility Inc. in the Education category, currently rated 2.9★ across 218 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.

Quality Score is 41: Emerging (early traction worth watching). For a Education app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

💰 Monthly revenue · now vs forecast
● Right now
$5.0K
per month
12-mo forecast
$5.2K – $10.8K
per month
24-mo forecast
$6.4K – $19.2K
per month
MID tierSUBSCRIPTION
💡 Grow this revenue
Free AI audit of this app’s store listing
  • Title & subtitle keyword fit
  • Description hook & conversion structure
  • Screenshots, ratings, reviews strategy
Run free AI audit →
Typical impact: +2-5× organic installs
🔔Notify me when this app's revenue changes by

📊 Performance Tracking LIVE

80 snapshots on record
idle
0%
Rating
2.9
Reviews
218 reviews
Forecast Revenue / mo
$5.0K
Snapshots tracked
80
since Dec 2020
ONE-TIME · BUILD 💰 Estimated build cost
$140K
What it cost to build · not monthly revenue
Likely range $105K – $190K
$25K · MVP floor $100K · indie scale $500K+ · studio build
📈 Pays back in ~2.3y at current MRR

Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.

Where the money goes
🧱 MVP baseline (design + 1-store ship) +$28K
📱 5 unique screens × $4.5K +$22K
📦 Asset bundle (142 MB) +$36K
Education complexity ×1.20 +$17K
5.8y maintenance × ~1-person team +$34K
Total estimate $140K
ONE-TIME · EXIT VALUE 💵 Estimated acquisition value
$75K
What it would sell for · not monthly revenue
Marketplace range $50K – $100K · 14× MRR multiple
💸 ~0.5× build cost (under-water)

Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.

How the multiple was built
📺 Ad-supported base 15× MRR
📅 5.8y proven track record +20%
★ rating < 3.5 (weak) -18%
🏷 Education category multiple +6%
Small user base (<1K ratings) -8%
Final multiple 14× MRR
👥 Estimated audience size
13K
Lifetime downloads (US-equivalent)
Monthly active
1.8K
Daily active
540

Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.

How we sized it
📲 Education engagement ~85 installs / rating
📅 5.8y of rating accumulation -29%
🔁 Education D30 retention 18%
📍 DAU / MAU stickiness 0.30
DAU / MAU 30% sticky
🛠 Estimated tech stack
🍎
Native iOS (SwiftUI)
Medium confidence · 60%
Also possible
React Native Flutter

Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.

Signals we read
📦 App bundle size 142 MB
🏷 Category context Education
📦 Mid-large iOS bundle → Likely native SwiftUI (post-2020 era)
💀 Maintenance status
Slowing
25%
Last shipped 2026-08-18 · 37 days ago
0 · Active 50 · At risk 100 · Abandoned

Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.

Risk signals
📅 37 days since last update Healthy release cadence
👥 Small user base (218 ratings) + 5.8y old +10% (solo-project pattern)
Verdict Slowing
🔬

How we forecast this revenue

MEDIUM CONFIDENCE
Baseline
$5.0K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
Direction
Tailwinds: monetization model proven
Headwinds: rating drift may slow acquisition
6 months
$4.7K – $7.9K
12 months
$5.2K – $10.8K
24 months
$6.4K – $19.2K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊

BU Investment Matrix

Below median · 45/100MID TIERSUBSCRIPTIONunderperforming peers
GrowthFounderQualityRevenueMonetiz.MoatMarketSafety
Growth Velocity
5.0
Founder Strength
3.0
Product Quality
2.6
Revenue Strength
3.7
Monetization Maturity
9.5
Defensibility
6.0
Market Position
2.0
Operational Safety
4.3
  • 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
  • ⭐ Quality: 2.93★ across 218 reviews — weak — significant quality concerns.
  • 📍 Market: Not yet charting in any of the 9 monitored markets.
  • 📈 Growth: Insufficient signal to assess trajectory.
  • ⚠️ Risk: Elevated — 22% subscription complaints, rating drift -0.59 ★ (recent 50 vs lifetime).
🎯 For competitors: Vulnerable. Quality drift + slow updates create a clear opening for a fresh competitor with active dev cadence.
💵 For acquirers: Estimated asking range 12-22× monthly = $60K-$110K. Discount applied for operational risk..
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:

💰 Forecast Revenue / mo

MODEL
Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 11 of 11 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
bugsREVIEW
−$1,800
5 starREVIEW
+$1,800
Below-average rating (2.9★)METRIC
−$1,500
highly recommendREVIEW
+$1,400
slowREVIEW
−$1,200
too expensiveREVIEW
−$1,000
support teamREVIEW
+$900
priceyREVIEW
−$800
Established app (5y old)METRIC
+$800
Ad-supported / freemiumMETRIC
+$600
Early-stage install base (218 ratings)METRIC
+$400
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📈 Reviews Growth

LIVE
Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE
Average rating evolution. Updates with each new review batch.

🆕 What's New · v3.13.2

v3.13.2 Update

This update delivers a more intelligent AI and an enhanced user experience by improving app performance and usability.

[Improvements]

Enhanced AI Recognition Performance: The AI engine has been upgraded to improve object recognition performance and stability.… Full release notes →

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name
PillEye – tablet, pill counter
Developer
Medility Inc.
Bundle ID
com.rocateer.mediscount
App Store URL
Open in App Store
Category
Education
Content rating
4+
Languages
EN, JA, KO

Company

Website
Not found
Tagline
Today
Description
Find apps and games for iPhone, iPad, Mac, and more on the App Store.
Founded
Not found
HQ / Address
Not found
Employees
Not found
Logo
Available

Revenue

Reported revenue signal / mo
Not found
AI revenue estimate / mo
Not found
AI annual estimate
Not found
Model estimate / mo
$5.0K/mo
Top-grossing rank
🇨🇦#21 /100   🇯🇵#36 /100   🇺🇸#53 /100   🇦🇺#92 /100
All-time revenue
Not found
Pricing
Not found

Founder

Founder data not yet collected for this app.

Funding

Funding data not yet collected for this app.

Press & Links

Press & Links data not yet collected for this app.

Contacts & Socials

Contacts & Socials data not yet collected for this app.
📈Ratings growth223 ratings+260% lifetimeShow 3-year history estimate ▾Nov 2023Jun 2026Sep 2026
Tracked (60 weeks) Pre-tracking estimate (0 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Top Countries — Grossing Rank4 countries
🇨🇦CA
#21 /100
🇯🇵JP
#36 /100
🇺🇸US
#53 /100
🇦🇺AU
#92 /100
📊Category Rank Trajectory#21 now · best #21 · worst #21
Lower line = better rank · Estimate from ratings growth model · Lower position on chart = worse rank · Higher = top of chart
🚀Update Frequency · Releases per Quarter2 releases tracked
11Q2 2026Q3 2026
🚀Version Release Timeline2 releases tracked
v3.13.1May 2026v3.13.2Sep 2026
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

📝 About this app

PillEye – Revolutionize Pill Counting
Stop manually counting pills and switch to a faster, more accurate service with PillEye. Built for pharmacists, pharmacy technicians, veterinarians, and healthcare professionals, PillEye delivers precision and efficiency like never before.

Key Features:
- Photo Mode – Snap and Count: Capture a single photo to count up to 500 pills with unmatched precision.
- 99.99% Accuracy: Whether you’re counting tablets, capsules, or halves, PillEye ensures every count is precise.
- History Management: Save, review, and share your pill counts seamlessly with your team.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →
💾 142 MB🔞 4+📱 iOS 13.0+🔖 v3.13.2🔄 updated 1mo ago🌐 EN, JA, KO📂 Education💰 Free🚀 Launched 2020 (5y old)
📅

What Worked™ · Development Pipeline

13 EVENTS TRACKED
Detected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-08
🔧
Shipped update — v3.13.1 → v3.13.2
2026-05
🔄
Monetization changed: freemium → free
2026-05
Rating ↓ 5.00 → 2.93 (dropped 2.07★)
2026-03
Rating ↑ 2.38 → 5.00 (improved 2.62★)
→ 30 days after: rating +2.62★ · reviews +124 high confidence
2026-03
📈
Crossed 100 ratings — social-proof flywheel kicking in
→ 30 days after: rating +2.62★ · reviews +124 high confidence
2023-08
📈
Crossed 50 ratings — social-proof flywheel kicking in
→ 30 days after: rating +0.10★ high confidence
2023-08
📈
Crossed 50 ratings — social-proof flywheel kicking in
→ 30 days after: reviews +6 high confidence
2022-03
📈
Crossed 10 ratings — social-proof flywheel kicking in
2022-03
📈
Crossed 10 ratings — social-proof flywheel kicking in
→ 30 days after: rating −0.19★ high confidence
2021-05
Rating ↑ 2.80 → 3.17 (improved 0.37★)
2021-01
Rating ↑ 2.33 → 3.00 (improved 0.67★)
→ 30 days after: rating +2.00★ medium · co-occurring
2021-01
Rating ↑ 1.00 → 2.50 (improved 1.50★)
→ 30 days after: rating +2.00★ medium · co-occurring
2020-12
🚀
First tracked snapshot — initial data captured
→ 30 days after: rating +2.00★ medium · co-occurring
🗣

Voice of Customer

Based on 94 reviews across 2 markets
● 67% positive  ·  ● 10% neutral  ·  ● 23% negative  ·  Rating drift: -0.59★ (declining — recent 50: 2.34★ vs lifetime: 2.93★)
−10+12022-Q12023-Q12023-Q22023-Q32023-Q42024-Q12024-Q22024-Q4
VADER compound sentiment per quarter (−1 = fully negative, +1 = fully positive). Each point ≥ 5 reviews.
Sentiment by country (−1 to +1)
🇺🇸 US
+0.33
🇦🇺 AU
+0.17
Top praise themes
accurate ×12 count ×11 pills ×10 counting ×10 works ×7 one ×5 recommend ×5 easy ×5
Top complaint themes
doesn work ×5 per month ×5 count pills ×4 sign required ×4 new update ×3 inventory counts ×3 ridiculous subscription ×3 dollars month ×3
Risk signals
Subscription complaints: 22%
🌍

Multi-Country Performance

Available in 9 of 9 monitored markets
MarketRatingReviewsCurrent version
🇦🇺 AU3.4★53.4★ this version
🇧🇷 BR0★0
🇨🇦 CA2.44736★382.44736★ this version
🇩🇪 DE1★11★ this version
🇫🇷 FR0★0
🇬🇧 GB5★65★ this version
🇮🇳 IN5★25★ this version
🇯🇵 JP2.54762★422.54762★ this version
🇺🇸 US2.94619★2232.94619★ this version
🔔

Track this app’s revenue

FREE
Get an email when revenue moves by your threshold. No spam, unsubscribe in one click.

📝 Description

95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for PillEye – tablet, pill counter: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
Read deep-dive →

Similar apps in Education

About this analysis
ZCAnalyzed by Zakhar Chumak · founder, Bumetric·Full methodology·Medium confidence

Why medium confidence: 218 ratings · no founder-verified revenue (model estimate only).

Frequently Asked Questions

10 answers · auto-generated from this app's public data
How much does PillEye – tablet, pill counter make per month?
Based on our ML-calibrated revenue forecast, PillEye – tablet, pill counter earns approximately $5.0K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
Is PillEye – tablet, pill counter profitable?
With estimated build cost $140K and monthly revenue $5.0K, PillEye – tablet, pill counter looks break-even-grade — payback period sits around 2.3 years. Profitability also depends on paid-acquisition spend and refund rate which the public model doesn't see.
How many users does PillEye – tablet, pill counter have?
Estimated audience: ~13K lifetime downloads, ~1K monthly active users, and ~540 daily active users. Derived from ratings count × category installs-per-rating × age decay. US-storefront-equivalent — global audience can be 5-10× larger for internationally-distributed apps.
What apps are like PillEye – tablet, pill counter?
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
What is PillEye – tablet, pill counter built with?
Our heuristic places PillEye – tablet, pill counter on the Native iOS (SwiftUI) stack (Medium confidence, 60%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: React Native, Flutter.
Is PillEye – tablet, pill counter still actively maintained?
Maintenance status: Slowing (25% abandonment risk). Last shipped version was 1 months ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.
How much would PillEye – tablet, pill counter sell for?
Estimated acquisition value: $75K (marketplace range $50K – $100K). Calculated as 14× monthly revenue using the standard multiple for the detected monetization model + adjustments for age, rating quality and category demand. Calibrated against 2024-2026 Flippa / Acquire.com / MicroAcquire closed-deal medians.
When was PillEye – tablet, pill counter last updated?
PillEye – tablet, pill counter last shipped a new version on 2026-08-18 — 1 months ago. This is the date Apple / Google last accepted a new build, not a content-only push.
Who makes PillEye – tablet, pill counter?
PillEye – tablet, pill counter is published by Medility Inc. on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is PillEye – tablet, pill counter's BU Score?
PillEye – tablet, pill counter has a BU Score of 41/100 (Emerging). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.